EXAS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: November 08, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Exact Sciences Corp (EXAS)

Based on 34 analysts giving stock ratings to Exact Sciences Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
38
Buy
50
Hold
12
Sell
0
Strong Sell
0
Exact Sciences Corp

Exact Sciences Corp. Stock Analysis EXAS

United States Health Care Large Cap Report:
EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,900 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Read More

Exact Sciences Corp (EXAS) Chart

Exact Sciences Corp (EXAS) vs CBOE Volatility Index (VIX) Comparative Returns

Analysis of Exact Sciences Corp (EXAS) stock performance compared to the broader market (CBOE Volatility Index (VIX)) across multiple timeframes.

YTD Performance
  • Exact Sciences ... (EXA...) 1.65%
  • CBOE Volatility Index (VIX) 7.42%
Exact Sciences Corp Underperformed CBOE Volatility Index (VIX) by 5.77%
1Y Performance
  • Exact Sciences ... (EXA...) 104.07%
  • CBOE Volatility Index (VIX) -3.02%
Exact Sciences Corp Outperformed CBOE Volatility Index (VIX) by 107.09%
3Y Performance
  • Exact Sciences ... (EXA...) 57.57%
  • CBOE Volatility Index (VIX) -19.46%
Exact Sciences Corp Outperformed CBOE Volatility Index (VIX) by 77.03%
5Y Performance
  • Exact Sciences ... (EXA...) -33.4%
  • CBOE Volatility Index (VIX) -51.47%
Exact Sciences Corp Outperformed CBOE Volatility Index (VIX) by 18.07%

Key Statistics of Exact Sciences Corp (EXAS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$103.19$103.46

Today's Open

$103.23

Volume

2.09M

P/E Ratio (TTM)

-

52 Week Range

$38.81$103.54

Market Cap

19.53B

Avg. Volume

2.33M

Dividend Yield

-

Financial Metrics & Statements of Exact Sciences Corp (EXAS)

Super Investors Invested in Exact Sciences Corp (EXAS)

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

Community-Curated Collections with Exact Sciences Corp (EXAS) ( With EXAS )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Exact Sciences Corp (EXAS)

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.